Literature DB >> 28094170

Common developmental genome deprogramming in schizophrenia - Role of Integrative Nuclear FGFR1 Signaling (INFS).

S T Narla1, Y-W Lee2, C A Benson1, P Sarder2, K J Brennand3, E K Stachowiak1, M K Stachowiak4.   

Abstract

The watershed-hypothesis of schizophrenia asserts that over 200 different mutations dysregulate distinct pathways that converge on an unspecified common mechanism(s) that controls disease ontogeny. Consistent with this hypothesis, our RNA-sequencing of neuron committed cells (NCCs) differentiated from established iPSCs of 4 schizophrenia patients and 4 control subjects uncovered a dysregulated transcriptome of 1349 mRNAs common to all patients. Data reveals a global dysregulation of developmental genome, deconstruction of coordinated mRNA networks, and the formation of aberrant, new coordinated mRNA networks indicating a concerted action of the responsible factor(s). Sequencing of miRNA transcriptomes demonstrated an overexpression of 16 miRNAs and deconstruction of interactive miRNA-mRNA networks in schizophrenia NCCs. ChiPseq revealed that the nuclear (n) form of FGFR1, a pan-ontogenic regulator, is overexpressed in schizophrenia NCCs and overtargets dysregulated mRNA and miRNA genes. The nFGFR1 targeted 54% of all human gene promoters and 84.4% of schizophrenia dysregulated genes. The upregulated genes reside within major developmental pathways that control neurogenesis and neuron formation, whereas downregulated genes are involved in oligodendrogenesis. Our results indicate (i) an early (preneuronal) genomic etiology of schizophrenia, (ii) dysregulated genes and new coordinated gene networks are common to unrelated cases of schizophrenia, (iii) gene dysregulations are accompanied by increased nFGFR1-genome interactions, and (iv) modeling of increased nFGFR1 by an overexpression of a nFGFR1 lead to up or downregulation of selected genes as observed in schizophrenia NCCs. Together our results designate nFGFR1 signaling as a potential common dysregulated mechanism in investigated patients and potential therapeutic target in schizophrenia.
Copyright © 2016 The Authors. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Developmental hypothesis; Fibroblast Growth Factor Receptor 1; Genome regulation; Schizophrenia; miRNA

Mesh:

Substances:

Year:  2017        PMID: 28094170      PMCID: PMC5507209          DOI: 10.1016/j.schres.2016.12.012

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  97 in total

1.  A comprehensive analysis of the distribution of FGF-2 and FGFR1 in the rat brain.

Authors:  A M Gonzalez; M Berry; P A Maher; A Logan; A Baird
Journal:  Brain Res       Date:  1995-12-01       Impact factor: 3.252

2.  Coordination of fibroblast growth factor receptor 1 (FGFR1) and fibroblast growth factor-2 (FGF-2) trafficking to nuclei of reactive astrocytes around cerebral lesions in adult rats.

Authors:  W E Clarke; M Berry; C Smith; A Kent; A Logan
Journal:  Mol Cell Neurosci       Date:  2001-01       Impact factor: 4.314

Review 3.  Modeling heterogeneous patients with a clinical diagnosis of schizophrenia with induced pluripotent stem cells.

Authors:  Kristen J Brennand; Melissa A Landek-Salgado; Akira Sawa
Journal:  Biol Psychiatry       Date:  2013-11-15       Impact factor: 13.382

4.  High frequencies of de novo CNVs in bipolar disorder and schizophrenia.

Authors:  Dheeraj Malhotra; Shane McCarthy; Jacob J Michaelson; Vladimir Vacic; Katherine E Burdick; Seungtai Yoon; Sven Cichon; Aiden Corvin; Sydney Gary; Elliot S Gershon; Michael Gill; Maria Karayiorgou; John R Kelsoe; Olga Krastoshevsky; Verena Krause; Ellen Leibenluft; Deborah L Levy; Vladimir Makarov; Abhishek Bhandari; Anil K Malhotra; Francis J McMahon; Markus M Nöthen; James B Potash; Marcella Rietschel; Thomas G Schulze; Jonathan Sebat
Journal:  Neuron       Date:  2011-12-22       Impact factor: 17.173

Review 5.  "Nuclear FGF receptor-1 and CREB binding protein: an integrative signaling module".

Authors:  Michal K Stachowiak; B Birkaya; J M Aletta; S T Narla; C A Benson; B Decker; E K Stachowiak
Journal:  J Cell Physiol       Date:  2015-05       Impact factor: 6.384

Review 6.  Endophenotypes in the genetic analyses of mental disorders.

Authors:  Tyrone D Cannon; Matthew C Keller
Journal:  Annu Rev Clin Psychol       Date:  2006       Impact factor: 18.561

7.  Rare chromosomal deletions and duplications increase risk of schizophrenia.

Authors: 
Journal:  Nature       Date:  2008-07-30       Impact factor: 49.962

Review 8.  White matter changes in schizophrenia: evidence for myelin-related dysfunction.

Authors:  Kenneth L Davis; Daniel G Stewart; Joseph I Friedman; Monte Buchsbaum; Philip D Harvey; Patrick R Hof; Joseph Buxbaum; Vahram Haroutunian
Journal:  Arch Gen Psychiatry       Date:  2003-05

9.  Integrative nuclear FGFR1 signaling (INFS) pathway mediates activation of the tyrosine hydroxylase gene by angiotensin II, depolarization and protein kinase C.

Authors:  Hu Peng; Jason Myers; Xiaohong Fang; Ewa K Stachowiak; Pamela A Maher; Gabriel G Martins; Gabriela Popescu; Ronald Berezney; Michal K Stachowiak
Journal:  J Neurochem       Date:  2002-05       Impact factor: 5.372

10.  Large recurrent microdeletions associated with schizophrenia.

Authors:  Hreinn Stefansson; Dan Rujescu; Sven Cichon; Olli P H Pietiläinen; Andres Ingason; Stacy Steinberg; Ragnheidur Fossdal; Engilbert Sigurdsson; Thordur Sigmundsson; Jacobine E Buizer-Voskamp; Thomas Hansen; Klaus D Jakobsen; Pierandrea Muglia; Clyde Francks; Paul M Matthews; Arnaldur Gylfason; Bjarni V Halldorsson; Daniel Gudbjartsson; Thorgeir E Thorgeirsson; Asgeir Sigurdsson; Adalbjorg Jonasdottir; Aslaug Jonasdottir; Asgeir Bjornsson; Sigurborg Mattiasdottir; Thorarinn Blondal; Magnus Haraldsson; Brynja B Magnusdottir; Ina Giegling; Hans-Jürgen Möller; Annette Hartmann; Kevin V Shianna; Dongliang Ge; Anna C Need; Caroline Crombie; Gillian Fraser; Nicholas Walker; Jouko Lonnqvist; Jaana Suvisaari; Annamarie Tuulio-Henriksson; Tiina Paunio; Timi Toulopoulou; Elvira Bramon; Marta Di Forti; Robin Murray; Mirella Ruggeri; Evangelos Vassos; Sarah Tosato; Muriel Walshe; Tao Li; Catalina Vasilescu; Thomas W Mühleisen; August G Wang; Henrik Ullum; Srdjan Djurovic; Ingrid Melle; Jes Olesen; Lambertus A Kiemeney; Barbara Franke; Chiara Sabatti; Nelson B Freimer; Jeffrey R Gulcher; Unnur Thorsteinsdottir; Augustine Kong; Ole A Andreassen; Roel A Ophoff; Alexander Georgi; Marcella Rietschel; Thomas Werge; Hannes Petursson; David B Goldstein; Markus M Nöthen; Leena Peltonen; David A Collier; David St Clair; Kari Stefansson
Journal:  Nature       Date:  2008-09-11       Impact factor: 49.962

View more
  15 in total

Review 1.  Modeling schizophrenia pathogenesis using patient-derived induced pluripotent stem cells (iPSCs).

Authors:  Haneul Noh; Zhicheng Shao; Joseph T Coyle; Sangmi Chung
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2017-06-28       Impact factor: 5.187

2.  Rare Variants in Tissue Inhibitor of Metalloproteinase 2 as a Risk Factor for Schizophrenia: Evidence From Familial and Cohort Analysis.

Authors:  Jibin John; Aditya Sharma; Prachi Kukshal; Triptish Bhatia; Vishwajit L Nimgaonkar; Smita N Deshpande; B K Thelma
Journal:  Schizophr Bull       Date:  2019-01-01       Impact factor: 9.306

3.  Multiple rare inherited variants in a four generation schizophrenia family offer leads for complex mode of disease inheritance.

Authors:  Jibin John; Upasana Bhattacharyya; Navneesh Yadav; Prachi Kukshal; Triptish Bhatia; V L Nimgaonkar; Smita N Deshpande; B K Thelma
Journal:  Schizophr Res       Date:  2019-12-05       Impact factor: 4.939

4.  Differential Brain and Cerebrospinal Fluid Proteomic Responses to Acute Prenatal Endotoxin Exposure.

Authors:  Tik Muk; Allan Stensballe; Oksana Dmytriyeva; Anders Brunse; Ping-Ping Jiang; Thomas Thymann; Per Torp Sangild; Stanislava Pankratova
Journal:  Mol Neurobiol       Date:  2022-01-21       Impact factor: 5.590

Review 5.  Fibroblast Growth Factor Signalling in the Diseased Nervous System.

Authors:  Lars Klimaschewski; Peter Claus
Journal:  Mol Neurobiol       Date:  2021-04-15       Impact factor: 5.590

6.  What genes are differentially expressed in individuals with schizophrenia? A systematic review.

Authors:  Alison K Merikangas; Matthew Shelly; Alexys Knighton; Nicholas Kotler; Nicole Tanenbaum; Laura Almasy
Journal:  Mol Psychiatry       Date:  2022-01-28       Impact factor: 13.437

7.  Genetically-Informed Patient Selection for iPSC Studies of Complex Diseases May Aid in Reducing Cellular Heterogeneity.

Authors:  Stephanie D Hoekstra; Sven Stringer; Vivi M Heine; Danielle Posthuma
Journal:  Front Cell Neurosci       Date:  2017-06-13       Impact factor: 5.505

Review 8.  Tracing Early Neurodevelopment in Schizophrenia with Induced Pluripotent Stem Cells.

Authors:  Ruhel Ahmad; Vincenza Sportelli; Michael Ziller; Dietmar Spengler; Anke Hoffmann
Journal:  Cells       Date:  2018-09-17       Impact factor: 6.600

9.  Commonality in dysregulated expression of gene sets in cortical brains of individuals with autism, schizophrenia, and bipolar disorder.

Authors:  Jinting Guan; James J Cai; Guoli Ji; Pak Chung Sham
Journal:  Transl Psychiatry       Date:  2019-05-24       Impact factor: 6.222

10.  Cerebral organoids reveal early cortical maldevelopment in schizophrenia-computational anatomy and genomics, role of FGFR1.

Authors:  E K Stachowiak; C A Benson; S T Narla; A Dimitri; L E Bayona Chuye; S Dhiman; K Harikrishnan; S Elahi; D Freedman; K J Brennand; P Sarder; M K Stachowiak
Journal:  Transl Psychiatry       Date:  2017-11-17       Impact factor: 6.222

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.